Project funded by the European Union

Polish version

INGENIX.AI Sp. z o.o.has received funding from the European Union for the project “Application of Breakthrough Multimodal Generative Artificial Intelligence Methods for Predicting Clinical Trial Outcomes”. The project is being implemented to increase the effectiveness of clinical trials and reduce the costs of developing new drugs through the use of advanced multimodal artificial intelligence methods. As part of the project, we plan to develop AI models for predicting drug toxicity and efficacy at the molecular, cellular, and population levels, as well as to create advanced data processing pipelines. The result of the project will be an innovative AI tool capable of analyzing clinical trial protocols, predicting the probability of trial success, and recommending changes to improve their effectiveness. The project outcomes will benefit pharmaceutical and biotechnology companies, as well as teams conducting clinical trials in Poland and abroad.

#EUFunds #EuropeanFunds

Project value: PLN 25,629,370.36
EU funding contribution: PLN 18,855,422.40